The Literature By Darrell WuDunn, MD, PhD, and Joshua W. Evans, MD
Highlights of the AGS Annual Meeting
The latest results of clinical trials and research studies presented at the 27th Annual Meeting of the American Glaucoma Society, held March 2 to 5, 2017, in Coronado, California.
By Ambika Hoguet, MD, and Lucy Q. Shen, MD
Where We Are Today With MIGS With Leon W. Herndon, MD; Oluwatosin U. Smith, MD; Mahmoud A. Khaimi, MD; Sameh Mosaed, MD; Michael D. Greenwood, MD; Steven R. Sarkisian Jr, MD; Michael Berlin, MD, MS; Vigan Roka, MD; Michael Riggs; and Ulrich Giers, MD; Steven D. Vold, MD; Marc Töteberg-Harms, MD, FEBO; Erik L. Mertens, MD, FEBOphth, and Howard Barnebey, MD
Research Update on Laser Trabeculoplasty
A literature search reveals interesting findings from 2016.
By Tony Realini, MD, MPH
A Targeted Approach
Endocyclophotocoagulation for glaucoma management.
By Chungkwon Yoo, MD, PhD, and Shan C. Lin, MD
Using this treatment option earlier in the disease course and in sighted eyes.
By James Fox, MD
The Role of Surgery
A blueprint for treatment.
By Edward S. Yung, MD, and Marlene R. Moster, MD
New Diagnostic Tools
OCT angiography, PERG, and corneal hysteresis.
By Jonathan S. Myers, MD
The Literature By David L. Phillips, MD, and Norman A. Zabriskie, MD
The Role of Perfusion Pressure
Risk factors other than IOP play a role in the pathogenesis of glaucoma.
By Robert N. Weinreb, MD; Jeffrey M. Liebmann, MD; and Louis R. Pasquale, MD
Point/Counterpoint: Has a Replacement for Trabeculectomy Finally Arrived? By Davinder S. Grover, MD, MPH, and Steven J. Gedde, MD
Journey to the Cutting Edge
Nonaccredited ophthalmology meetings preview the future.
By Larissa Camejo, MD
A Case of Pediatric Sturge-Weber Syndrome
The steps that saved the vision of a 3-year-old girl.
By Jayasree Venugopal, MS, MBBS
A mainstay of glaucoma management today and tomorrow.
By Robert D. Fetchner, MD, and Albert S. Khouri, MD
Options for decreasing ocular toxicity in patients with glaucoma.
By Arkadiy Yadgarov, MD, and Reena A. Garg, MD
On The Horizon
New medications give fresh hope for treating glaucoma.
By Jason Bacharach, MD
Sustained-Release Drug Delivery: the Future of Glaucoma Treatment
Several devices are being investigated.
By Justin A. Schweitzer, OD, FAAO, and Mitch Ibach, OD, FAAO
Phaco-Goniosynechialysis: Tap, Sweep, and Tweep By Jonathan S. Myers, MD
From the Trenches
What is maximal medical therapy today? Three physicians share their thoughts.
By Howard Barnebey, MD; Carla J. Siegfried, MD; and Julia Song, MD
The Adherence Problem
Its scope and strategies for its reduction.
By Henry D. Jampel, MD, MHS
Glaucoma in the Octogenarian
Considerations in treating the advanced elderly.
By Samuel P. Solish, MD
The Literature By Jonathan Paul, MD, and Sheila Sanders, MD
Cataract Surgery Alone—an Underused Solution?
One of the most common ophthalmic surgical tools achieves more than its primary intended purpose.
By Nicholas Bell, MD
Suprachoroidal Access: the Next Big Thing?
This new class of devices will allow further customization of glaucoma therapy.
By Cynthia Mattox, MD
Gonioscopy Is Essential for MIGS
This critical skill set comprises more than docking the goniolens.
By Shakeel Shareef, MD
Tools of the Trade
Instruments essential to any successful trabeculectomy.
By Jon M. Ruderman, MD, and Sara R. Ghobraiel, MD
MIGS in Kids
Recent advances may reshape the traditional paradigm.
By Ta Chen Peter Chang, MD
The Results Are in: 2016 Film Festival Winner Announced
Congratulations to Shakeel Shareef, MD, the winner of the GT 2016 Film Festival.
To the FDA With Appreciation By Steven D. Vold, MD
The Literature By Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD
What Is the Real IOP?
Laboratory studies may help us better understand our clinical dilemmas.
By Dan Eisenberg, MD
Highlights of the 2016 ARVO Annual Meeting
Select research findings presented this year.
By Sze H. Wong, MD, and Albert S. Khouri, MD
News Feature: a New Option for Uveitis
Adalimumab, a rheumatology drug, offers hope to patients with this damaging inflammatory eye disease.
By Agustin L. Gonzalez, OD
Glaucoma After Corneal Limbal Stem Cell Transplantation By Ahmad A. Aref, MD; Kavitha R. Sivaramen, MD; and Ali R. Djalilian, MD
Foundations of a Great Physician By Linda Huang, MD
Ocular Surface Disease: Impact on Glaucoma Surgical Decision Making
The preoperative planning process is more complex and requires careful attention to the unique issues at play.
By Tony Realini, MD, MPH
The Dark Side of Medication
Many systemic and topical drugs can cause or worsen dry eye disease.
By Sarah Marshall, PhD, and Robert Noecker, MD, MBA
Tear Osmolarity in a Glaucoma Practice
The role of point-of-care testing in dry eye disease and glaucoma management.
By Leslie E. O’Dell, OD